• Tweet

IN THIS ISSUE:

FEATURE: New Drugs in Opiate Addiction Battle.
As the overdose statistics continue to rise the need for innovative ways to deal with the Opiate epidemic. Can new drugs be the answer? A look at three promising advances.

COMPANY NEWS:
OncoSec Advances IL 12 Immunotherpy for Melanoma
Interpace Reports Year End Results
CymaBay Announces the Retirement of President, CEO, Harold Van Wart, Ph.D.
ITUS closes $4.7 Million Rights offering

INTERVIEWS:
Glynn Wilson, CEO of TapImmune on cancer treatment
David Buzkin, head of  Marcum’s SEC practice on IPO trends

IDEAS & TECHNOLOGIES:
Sensori AB- Medical Devices for the Human Senses with Common Sense
Genprex- Developing 21st Century Gene Therapies for Cancer
Leap Therapeutics- Developing Antibodies to Treat Cancer
SeaSpine- Most Advanced and Effective Spinal Surgery Technologies Worldwide

INDUSTRY NEWS:
Med Industry Associations joins to back MedTech Conference
BioCentury holds 24th Future Leaders Conference

Chinese Pharma Industry Leader Mingde Yu to Keynote Shanghai Conference